Letter to the editor.

Zeller, A; Czich, A; Guérard, M; Honarvar, N; Martus, H-J; Pfuhler, S; Vock, E; Kirkland, D.

Afiliación

Zeller A; F. Hoffmann-La Roche Ltd., Pharmaceutical Sciences, pRED Innovation Center Basel, 4070 Basel, Switzerland.
Czich A; Sanofi, Research and Development, Industriepark Hoechst, 65926 Frankfurt, Germany.
Guérard M; F. Hoffmann-La Roche Ltd., Pharmaceutical Sciences, pRED Innovation Center Basel, 4070 Basel, Switzerland.
Honarvar N; BASF SE, Experimental Toxicology and Ecology, Z470, 67056 Ludwigshafen, Germany.
Martus HJ; Novartis Institutes for BioMedical Research, 4057 Basel, Switzerland.
Pfuhler S; Global Product Stewardship, The Procter & Gamble Company, Cincinnati, OH, USA.
Vock E; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88379 Biberach an der Riss, Germany.
Kirkland D; Kirkland Consulting, PO Box 79, Tadcaster LS24 0AS, United Kingdom.

Mutat Res Genet Toxicol Environ Mutagen ; 876-877: 503473, 2022.

Article en En | MEDLINE | ID: mdl-35483788

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2022 Tipo del documento: Article